Chitosan–tripolyphosphate nanoparticles as Arrabidaea chica standardized extract carrier: Synthesis, characterization, biocompatibility, and antiulcerogenic activity

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 3897-3909

  Servat Medina, Leila ^a,b   González Gómez, Alvaro ^b,c   Reyes Ortega, Felisa ^b   Sousa, Ilza Maria Oliveira ^a   Queiroz, Nubia de Cássia Almeida ^a   Zago, Patricia Maria Wiziack ^a   Jorge, Michelle Pedrosa ^a   Monteiro, Karin Maia ^a   de Carvalho, João Ernesto ^a   San Román, Julio ^b,c   Foglio, Mary Ann ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b CSIC   (Spain)

^c BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

Arrabidaea chica; Chitosan; Herbal drug; Nanoparticle; Natural product; Plant extract; Ulcer healing

Indexed keywords

ANTIULCER AGENT; ARRABIDAEA CHICA EXTRACT; CHITOSAN; NANOPARTICLE; PLANT EXTRACT; POLYMER; RANITIDINE; TRIPOLYPHOSPHATE; UNCLASSIFIED DRUG; ALCOHOL; DRUG CARRIER; INDOMETACIN; PLANT MEDICINAL PRODUCT; POLYPHOSPHATE; TRIPHOSPHORIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIULCER ACTIVITY; ARRABIDAEA CHICA; ARTICLE; BIGNONIACEAE; BIOCOMPATIBILITY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DETERMINATION; DRUG MECHANISM; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HYDRODYNAMICS; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PHYTOCHEMISTRY; RAT; SCANNING ELECTRON MICROSCOPY; SKIN FIBROBLAST; STOMACH ULCER; ULCER HEALING; ZETA POTENTIAL; ANIMAL; CELL CULTURE; CELL SURVIVAL; CHEMICALLY INDUCED; CHEMISTRY; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; FIBROBLAST; MALE; METABOLISM; SKIN; WISTAR RAT;

ARRABIDAEA CHICA;

ANIMALS; BIGNONIACEAE; CELL SURVIVAL; CELLS, CULTURED; CHITOSAN; DISEASE MODELS, ANIMAL; DRUG CARRIERS; ETHANOL; FIBROBLASTS; HUMANS; INDOMETHACIN; MALE; NANOPARTICLES; PARTICLE SIZE; PHYTOCHEMICALS; PLANT EXTRACTS; POLYPHOSPHATES; RATS; RATS, WISTAR; SKIN; STOMACH ULCER;

EID: 84933576386     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S83705     Document Type: Article

References (56)

1. Joanitti GA, Silva LP. The emerging potential of by-products as platforms for drug delivery systems. Curr Drug Targets. 2014;15(5):478–485.
2. Zorn B, García-Piñeres AJ, Castro V, Murillo R, Mora G, Merfort I. 3-Desoxyanthocyanidins from Arrabidaea chica. Phytochemistry. 2001; 56(8):831–835.
3. Jorge MP, Madjarof C, Gois Ruiz AL, et al. Evaluation of wound healing properties of Arrabidaea chica Verlot extract. J Ethnopharmacol. 2008;118(3):361–366.
4. Aro AA, Simões GF, Esquisatto MA, et al. Arrabidaea chica extract improves gait recovery and changes collagen content during healing of the Achilles tendon. Injury. 2013;44(7):884–892.
5. Höfing JF, Anibal PC, Obando-Pereda GA, et al. Antimicrobial potential of some plant extracts against Candida species. Braz J Biol. 2010;70(4):1065–1068.
6. De Oliveira DPC, Borrás MRL, de Lima Ferreira LC, López-Lozano JL. [Anti-infammatory activity of the aqueous extract of Arrabidaea chica (Humb. & Bonpl.) B. Verl. on the self-induced infammatory process from venoms amazonians snakes]. Revista Brasileira de Farmacognosia. 2009;19(2b):643–649. Portuguese.
7. Siraichi JT, Felipe DF, Brambilla LZ, et al. Antioxidant capacity of the leaf extract obtained from Arrabidaea chica cultivated in Southern Brazil. PLoS One. 2013;8(8):e72733.
8. Ajazuddin, Saraf S. Applications of novel drug delivery system for herbal formulations. Fitoterapia. 2010;81(7):680–689.
9. Bonifácio BV, Silva PB, Ramos MA, Negri KM, Bauab TM, Chorilli M. Nanotechnology-based drug delivery systems and herbal medicines: a review. Int J Nanomedicine. 2014;9:1–15.
10. Luo Y, Wang Q. Recent development of chitosan-based polyelectrolyte complexes with natural polysaccharides for drug delivery. Int J Biol Macromol. 2014;64:353–367.
11. Garcia-Fuentes M, Alonso MJ. Chitosan-based drug nanocarriers: where do we stand? J Control Release. 2012;161(2):496–504.
12. Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ. Novel hydro-philic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci. 1997;63(1):125–132.
13. Zamora-Mora V, Fernández-Gutiérrez M, San Román J, Goya G, Hernández R, Mijangos C. Magnetic core-shell chitosan nanoparticles: rheological characterization and hyperthermia application. Carbohydr Polym. 2014;102:691–698.
14. Girones Molera J, Mendez JA, San Roman J. Bioresorbable and non-resorbable polymers for bone tissue engineering. Curr Pharm Des. 2012;18(18):2536–2557.
15. Muzzarelli RA, El Mehtedi M, Mattioli-Belmonte M. Emerging bio-medical applications of nano-chitins and nano-chitosans obtained via advanced eco-friendly technologies from marine resources. Mar Drugs. 2014;12(11):5468–5502.
16. Mogoşanu GD, Grumezescu AM. Natural and synthetic polymers for wounds and burns dressing. Int J Pharm. 2014;463(2):127–136.
17. Gomathysankar S, Halim AS, Yaacob NS. Proliferation of keratino-cytes induced by adipose-derived stem cells on a chitosan scaffold and its role in wound healing, a review. Arch Plast Surg. 2014;41(5): 452–457.
18. Paula JT, Paviani LC, Foglio MA, Sousa IMO, Cabral FA. Extraction of anthocyanins from Arrabidaea chica in fxed bed using CO2 and CO2/ethanol/water mixtures as solvents. J Supercrit Fluids. 2013;81:33–41.
19. Wen D, Li C, Di H, Liao Y, Liu H. A universal HPLC method for the determination of phenolic acids in compound herbal medicines. J Agric Food Chem. 2005;53(17):6624–6629.
20. Peniche C, Fernández M, Rodríguez G, et al. Cell supports of chitosan/ hyaluronic acid and chondroitin sulphate systems. Morphology and biological behaviour. J Mater Sci Mater Med. 2007;18(9): 1719–1726.
21. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methods. 1983;65(1–2):55–63.
22. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods. 1986;89(2): 271–277.
23. Vendramini-Costa DB, Monteiro KM, Iwamoto LH, et al. Gastroprotec-tive effects of goniothalamin against ethanol and indomethacin-induced gastric lesions in rats: Role of prostaglandins, nitric oxide and sulfhydryl compounds. Chem Biol Interact. 2014;224C:206–212.
24. Heinrich M, Barnes J, Gibbons S, Williamson EM. Fundamentals of Pharmacognosy and Phytotherapy. London, UK: Elsevier; 2007.
25. Figueira GM, Ramelo PR, Ogasawara DC, et al. A set of microsatellite markers for Arrabidaea chica (Bignoniaceae), a medicinal liana from the Neotropics. Am J Bot. 2010;97(7):e63–e64.
26. Taffarello D, Jorge MP, Sousa IMO, et al. [Activity of Arrabidaea chica (Humb. & Bonpl.) Verlot extracts obtained by biotechnological processes on fbroblast and human tumor cells]. Química Nova. 2013; 36(3):431–436. Portuguese.
27. Aro AA, Freitas KM, Foglio MA, et al. Effect of the Arrabidaea chica extract on collagen fber organization during healing of partially transected tendon. Life Sci. 2013;92(13):799–807.
28. Khoddami A, Wilkes MA, Roberts TH. Techniques for analysis of plant phenolic compounds. Molecules. 2013;18(2):2328–2375.
29. Barros F, Dykes L, Awika JM, Rooney L W. Accelerated solvent extraction of phenolic compounds from sorghum brans. J Cereal Sci. 2013; 58(2):305–312.
30. Gan Q, Wang T, Cochrane C, McCarron P. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf B Biointerfaces. 2005;44(2–3):65–73.
31. Lai P, Daear W, Löbenberg R, Prenner EJ. Overview of the preparation of organic polymeric nanoparticles for drug delivery based on gelatine, chitosan, poly(d,l-lactide-co-glycolic acid) and polyalkylcyanoacrylate. Colloids Surf B Biointerfaces. 2014;118:154–163.
32. Nasti A, Zaki NM, de Leonardis P, et al. Chitosan/TPP and chitosan/ TPP-hyaluronic acid nanoparticles: systematic optimisation of the preparative process and preliminary biological evaluation. Pharm Res. 2009;26(8):1918–1930.
33. Dong Y, Ng WK, Shen S, Kim S, Tan RB. Scalable ionic gelation synthesis of chitosan nanoparticles for drug delivery in static mixers. Carbohydr Polym. 2013;94(2):940–945.
34. Fàbregas A, Miñarro M, García-Montoya E, et al. Impact of physical parameters on particle size and reaction yield when using the ionic gelation method to obtain cationic polymeric chitosan-tripolyphosphate nanoparticles. Int J Pharm. 2013;446(1–2):199–204.
35. Li J, Huang Q. Rheological properties of chitosan-tripolyphosphate complexes: from suspensions to microgels. Carbohydr Polym. 2012; 87(2):1670–1677.
36. Konecsni K, Low NH, Nickerson MT. Chitosan-tripolyphosphate submicron particles as the carrier of entrapped rutin. Food Chem. 2012; 134(4):1775–1779.
37. Hu B, Pan C, Sun Y, Hou Z, Ye H, Zeng X. Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins. J Agric Food Chem. 2008;56(16):7451–7458.
38. Singh R, Lillard JW Jr. Nanoparticle-based targeted drug delivery. Exp Mol Pathol. 2009;86(3):215–223.
39. Reyes-Ortega F, Rodríguez G, Aguilar MR, et al. Encapsulation of low molecular weight heparin (bemiparin) into polymeric nanoparticles obtained from cationic block copolymers: properties and cell activity. J Mater Chem B Mater Biol Med. 2013;1:850–860.
40. Zhang H, Hussain I, Brust M, Butler MF, Rannard SP, Cooper AI. Aligned two- and three-dimensional structures by directional freezing of polymers and nanoparticles. Nat Mater. 2005;4(10):787–793.
41. Deville S, Saiz E, Nalla RK, Tomsia AP. Freezing as a path to build complex composites. Science. 2006;311(5760):515–518.
42. Aranaz I, Gutiérrez MC, Ferrer ML, del Monte F. Preparation of chitosan nanocomposites with a macroporous structure by unidirectional freezing and subsequent freeze-drying. Mar Drugs. 2014;12(11):5619–5642.
43. Jia S, Yang X, Song W, et al. Incorporation of osteogenic and angiogenic small interfering RNAs into chitosan sponge for bone tissue engineering. Int J Nanomedicine. 2014;9:5307–5316.
44. Noel SP, Courtney HS, Bumgardner JD, Haggard WO. Chitosan sponges to locally deliver amikacin and vancomycin: a pilot in vitro evaluation. Clin Orthop Relat Res. 2010;468(8):2074–2080.
45. Smith JK, Moshref AR, Jennings JA, Courtney HS, Haggard WO. Chitosan sponges for local synergistic infection therapy: a pilot study. Clin Orthop Relat Res. 2013;471(10):3158–3164.
46. Sylvester P W. Optimization of the tetrazolium dye (MTT) colorimetric assay for cellular growth and viability. In: Satyanarayanajois SD, editor. Drug Design and Discovery. Methods and Protocols. Los Angeles, CA: Humana Press; 2011:157–168.
47. International Organization for Standardization. ISO10993-5. Biological Evaluation of Medical Devices – Part 5: Tests for In Vitro Cytotoxicity. Geneva, Switzerland: International Organization for Standardization; 2009:1–34.
48. Heim KE, Tagliaferro AR, Bobilya DJ. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J Nutr Biochem. 2002;13(10):572–584.
49. Bors W, Michel C, Schikora S. Interaction of favonoids with ascorbate and determination of their univalent redox potentials: a pulse radiolysis study. Free Radic Biol Med. 1995;19(1):45–52.
50. Procházková D, Boušová I, Wilhelmová N. Antioxidant and prooxidant properties of favonoids. Fitoterapia. 2011;82(4):513–523.
51. Zhang Y, Yang Y, Tang K, Hu X, Zou G. Physicochemical characterization and antioxidant activity of quercetin-loaded chitosan nanoparticles. J Appl Polym Sci. 2008;107(2):891–897.
52. Glavin GB, Szabo S. Experimental gastric mucosal injury: laboratory models reveal mechanisms of pathogenesis and new therapeutic strategies. FASEB J. 1992;6(3):825–831.
53. Al Mofeh IA. Spices as alternative agents for gastric ulcer prevention and treatment. In: Chai J, editor. Peptic Ulcer Disease. Rijeka, Croatia: InTech; 2011:351–374.
54. 54. Jorge MP. Atividade cicatrizante de microencapsulados de extrato bruto etanólico obtido de Arrabidaea chica (HUMB. & BONPL.) Verlot. [Wound healing activity of microencapsulated of crude ethanolic extract obtained from Arrabidaea chica (HUMB. & BONPL.) Verlot.] [master’s thesis]. Campinas: Universidade Estadual de Campinas, Faculdade de Ciências Médicas; 2013. Brazil.
55. Strasser M, Noriega P, Löbenberg R, Bou-Chacra N, Bacchi EM. Anti-ulcerogenic potential activity of free and nanoencapsulated Passifora serratodigitata L. extracts. Biomed Res Int. 2014;2014:434067.
56. Suleyman H, Albayrak A, Bilici M, Cadirci E, Halici Z. Different mechanisms in formation and prevention of indomethacin-induced gastric ulcers. Infammation. 2010;33(4):224–234.